Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Actinium Pharmaceuticals, Inc. (Delaware) Common Stock (NY:ATNM)

1.525 +0.035 (+2.35%)
Streaming Delayed Price Updated: 3:22 PM EDT, Apr 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Actinium Pharmaceuticals, Inc. (Delaware) Common Stock

< Previous 1 2 3 4 Next >
Actinium Pharmaceuticals Rally Intact As Its Iomab-B Data Shows 100% Effectiveness In Targeted Patient Population (NYSE AMERICAN: ATNM)
Via AB Newswire
Actinium Pharmaceuticals Stock Jumps 17% Ahead Of SIERRA Trial Update; Iomab-B Shows 100% Effectiveness In Targeted Patient Population (NYSE AMERICAN: ATNM)
Via AB Newswire
48 Biggest Movers From Friday
Gainers Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares jumped 135.4% to settle at $5.32 on Friday. The stock possibly traded higher following favorable data results by... 
Via Benzinga
53 Biggest Movers From Yesterday
Gainers DICE Therapeutics, Inc. (NASDAQ: DICE) shares surged 117% to settle at $36.89 on Wednesday as the company priced its IPO at $17 per share. PROCEPT BioRobotics Corporation... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Why Actinium Pharmaceuticals' Stock Is Trading Higher Today
Actinium Pharmaceuticals (AMEX:ATNM) shares are trading higher after the company announced it completed enrollment in the pivotal Phase 3 SIERRA trial of iomab-B.... 
Via Benzinga
38 Stocks Moving In Wednesday's Mid-Day Session
Gainers Indaptus Therapeutics, Inc. (NASDAQ: INDP) shares jumped 177.2% to $19.60 after the company announced the United States Patent and Trademark Office has issued a notice of... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Mid-Day Market Update: monday.com Jumps Following Strong Q2 Results; Kubient Shares Plunge
Midway through trading Tuesday, the Dow traded down 0.81% to 35,336.88 while the NASDAQ fell 0.89% to 14,661.86. The S&P also fell, dropping 0.65% to 4,450.54. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
Actinium's Targeted Radiotherapy Achieves 100% Bone Marrow Transplant Engraftment
Actinium Pharmaceuticals Inc (NYSE: ATNM) highlighted data from its pivotal Phase 3 SIERRA trial evaluating Iomab-B in patients with relapsed or refractory Acute... 
Via Benzinga
Actinium Pharmaceuticals Details SIERRA at Benzinga Global Small Cap Business Conference
Actinium Pharmaceuticals Inc. (NYSE: ATNM), a clinical-stage biopharmaceutical company that develops antibody radiation-conjugates (ARC), took part in the Benzinga Global Small... 
Via Benzinga
Actinium Activates Radiation Inside the Body for Target Conditioning of Cancer Cells
Actinium Pharmaceuticals Inc. (NYSE: ATNM), a clinical-stage biopharmaceutical company, is developing antibody radiation-conjugates (ARCs) to combine the targeting ability of... 
Via Benzinga
Small-Cap Biotech Execs On Latest Advancements, Post-Pandemic Return To Fundamentals
At the Benzinga Global Small Cap Conference Thursday, Jason McCarthy, senior managing director at Maxim Group, hosted a panel discussion on how biotech companies are getting back... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.